Related Experiment Video
Updated: May 20, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Commensal-innate immune miscommunication in IBD pathogenesis.
1Division of Gastroenterology and Hepatology, University Hospital of Essen, Medical School-University of Duisburg-Essen, Essen, Germany. elke.cario@uni-due.de
The gut microbiota and innate immune system maintain a delicate balance. Miscommunication between them, often seen in inflammatory bowel disease (IBD), can drive gut inflammation and cancer.
Area of Science:
- Immunology
- Microbiology
- Gastroenterology
Background:
- The host innate immune system is crucial for intestinal health, distinguishing between harmless commensal microbes and pathogens.
- Constant, context-dependent interactions occur between commensals and innate immune cells within the gut mucosa.
- Factors like environment, genetics, and host defenses influence these complex interactions.
Purpose of the Study:
- To explore the intricate relationship between commensal microbiota and the host innate immune system in the intestinal mucosa.
- To understand how this interaction influences gut health and disease, particularly in the context of inflammatory bowel disease (IBD).
Main Methods:
- Review of existing literature on host-microbe interactions in the gut.
- Analysis of the role of innate immunity in maintaining mucosal homeostasis.
- Examination of factors contributing to immune dysregulation in IBD.
Main Results:
- Commensal microbiota and innate immunity are essential for intestinal barrier function.
- Dysbiosis, barrier defects, and immune deregulation can lead to miscommunication between commensals and the immune system.
- This miscommunication is a critical driver of mucosal inflammation and associated cancers.
Conclusions:
- Maintaining a balanced communication between commensal microbiota and the innate immune system is vital for gut health.
- Disruptions in this communication are implicated in the pathogenesis of IBD and gastrointestinal cancers.
- Further research into these interactions may reveal novel therapeutic targets.
More Related Videos
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease I: Introduction